Search research articles
Contact Us
Filters
Showing results (51-60 of 84) with videos related to
Page
of 9
Sort By:
Cell Death and Differentiation
|
March 9, 2018
A kinome-wide RNAi screen identifies ALK as a target to sensitize neuroblastoma cells for HDAC8-inhibitor treatment
Jing Shen, Sara Najafi, Sina Stäble, et al.
Nucleic Acids Research
|
April 30, 2013
MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastoma
Marco Lodrini, Ina Oehme, Christina Schroeder, et al.
Cell Death & Disease
|
August 25, 2025
High content-imaging drug synergy screening identifies specific senescence-related vulnerabilities of mesenchymal neuroblastomas
Sonja Herter, Marta Emperador, Kyriaki Smyrilli, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 1, 2015
Inhibition of Histone Deacetylases Permits Lipopolysaccharide-Mediated Secretion of Bioactive IL-1β via a Caspase-1-Independent Mechanism
Dominik Stammler, Tatjana Eigenbrod, Sarah Menz, et al.
Nature Communications
|
January 3, 2025
Genomic and phenotypic stability of fusion-driven pediatric sarcoma cell lines
Merve Kasan, Florian H Geyer, Jana Siebenlist, et al.
British Journal of Cancer
|
June 28, 2024
Synergy of retinoic acid and BH3 mimetics in MYC(N)-driven embryonal nervous system tumours
Till Seiboldt, Constantia Zeiser, Duy Nguyen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 27, 2013
Histone deacetylase 10 promotes autophagy-mediated cell survival
Ina Oehme, Jan-Peter Linke, Barbara C Böck, et al.
Chembiochem : a European Journal of Chemical Biology
|
May 24, 2022
First Fluorescent Acetylspermidine Deacetylation Assay for HDAC10 Identifies Selective Inhibitors with Cellular Target Engagement
Daniel Herp, Johannes Ridinger, Dina Robaa, et al.
Cancer Research
|
December 19, 2025
Integrative Multiomics and Drug Sensitivity Profiling Reveal Potential Biomarkers and Therapeutic Strategies in Pediatric Solid Tumors
Dina ElHarouni, Rosa Hernansaiz-Ballesteros, Heike Peterziel, et al.
Brain Pathology (Zurich, Switzerland)
|
October 8, 2015
Pediatric Targeted Therapy: Clinical Feasibility of Personalized Diagnostics in Children with Relapsed and Progressive Tumors
Florian Selt, Alica Deiß, Andrey Korshunov, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 84) with videos related to
Sort By:
Page
of 9
Cell Death and Differentiation
|
March 9, 2018
A kinome-wide RNAi screen identifies ALK as a target to sensitize neuroblastoma cells for HDAC8-inhibitor treatment
Jing Shen, Sara Najafi, Sina Stäble, et al.
Nucleic Acids Research
|
April 30, 2013
MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastoma
Marco Lodrini, Ina Oehme, Christina Schroeder, et al.
Cell Death & Disease
|
August 25, 2025
High content-imaging drug synergy screening identifies specific senescence-related vulnerabilities of mesenchymal neuroblastomas
Sonja Herter, Marta Emperador, Kyriaki Smyrilli, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 1, 2015
Inhibition of Histone Deacetylases Permits Lipopolysaccharide-Mediated Secretion of Bioactive IL-1β via a Caspase-1-Independent Mechanism
Dominik Stammler, Tatjana Eigenbrod, Sarah Menz, et al.
Nature Communications
|
January 3, 2025
Genomic and phenotypic stability of fusion-driven pediatric sarcoma cell lines
Merve Kasan, Florian H Geyer, Jana Siebenlist, et al.
British Journal of Cancer
|
June 28, 2024
Synergy of retinoic acid and BH3 mimetics in MYC(N)-driven embryonal nervous system tumours
Till Seiboldt, Constantia Zeiser, Duy Nguyen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 27, 2013
Histone deacetylase 10 promotes autophagy-mediated cell survival
Ina Oehme, Jan-Peter Linke, Barbara C Böck, et al.
Chembiochem : a European Journal of Chemical Biology
|
May 24, 2022
First Fluorescent Acetylspermidine Deacetylation Assay for HDAC10 Identifies Selective Inhibitors with Cellular Target Engagement
Daniel Herp, Johannes Ridinger, Dina Robaa, et al.
Cancer Research
|
December 19, 2025
Integrative Multiomics and Drug Sensitivity Profiling Reveal Potential Biomarkers and Therapeutic Strategies in Pediatric Solid Tumors
Dina ElHarouni, Rosa Hernansaiz-Ballesteros, Heike Peterziel, et al.
Brain Pathology (Zurich, Switzerland)
|
October 8, 2015
Pediatric Targeted Therapy: Clinical Feasibility of Personalized Diagnostics in Children with Relapsed and Progressive Tumors
Florian Selt, Alica Deiß, Andrey Korshunov, et al.
Page
of 9